Mitochondrial upkeep and senescent cell removal may jointly be required for longer life
Restoring mitochondrial maintenance in cardiomyocytes and muscle fibres together with removing chronically senescent fibroblasts may be required for lasting multisystem and lifespan benefits. Either intervention meeting the shared success criterion alone would refute the proposed requirement.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Metabolism and energy
Mitochondrial maintenance
The processes that maintain mitochondria within cells
Where this hypothesis actsIn cardiomyocytes and muscle fibers
Hypotheses on this target 1
Inhibition
Activation
Function preservation1
Supplementation
Feedback restoration
Direct measurement

What is proposed
Function preservation
Restore mitochondrial maintenance
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible lasting multisystem benefit and lifespan gain when combined with senescent fibroblast removal
From the recordM восстанавливает митохондриальное обслуживание кардиомиоцитов и мышечных волокон

Senescent cell
Senescent fibroblasts
Fibroblasts in a senescent state
Where this hypothesis actsChronically senescent fibroblasts that hinder tissue recovery
Hypotheses on this target 7
Function preservation2
Senolysis2
Senomorphic suppression1
Clearance restoration1
Reprogramming
Population balance

What is proposed
Senolysis
Remove senescent fibroblasts
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible lasting multisystem benefit and lifespan gain when combined with restored mitochondrial maintenance
From the recordC удаляет хронически сенесцентные фибробласты, мешающие восстановлению ткани.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Repairing one source of age-related decline may leave another source capable of preventing lasting recovery. The unexpected move is to treat two different repairs as one combined answer to the search for an intervention that benefits several body systems and extends life. This is a proposal generated by the pipeline, not a measured result: neither repair alone is predicted to achieve the full benefit.
- Restored upkeep repairs the maintenance of energy-producing structures inside heart and skeletal muscle cells.
- Cell removal eliminates persistent growth-arrested tissue-support cells proposed to obstruct tissue repair.
- Either intervention alone improves its immediate target but leaves the other proposed source of functional decline active.
- Together, the interventions are predicted to remove both obstacles and permit lasting benefits across several body systems and longer life.
- Reducing substances released by the persistent cells is predicted to substitute for neither intervention and add no benefit beyond a predefined margin when both are already present.
A workshop may need both its machinery repaired and its blocked work areas cleared before it can operate reliably. Completing only one job can improve something locally while leaving the workshop unable to function as a whole.
Where the picture breaks: Cells can change one another's behaviour, so repairing one process might also restore the other. The picture illustrates the proposed requirement for two repairs; it provides no evidence that biology actually requires both.
- Master questionstep 01 of 04
Age-related processes may reinforce one another, so changing a shared cause could benefit several body systems at once. The goal is to identify ideas that could extend life through such broad effects.
Rests on: The goal explicitly gives mutual reinforcement between ageing processes as the reason to search for a shared cause.
Stated in the chain - Goal pillarstep 02 of 04
The desired output is a collection of life-extension ideas that act through genuinely different causes.
Rests on: The master question requests multiple ideas for interventions with broad benefits. Distinguishing their causes makes explicit what would make them separate ideas.
Stated in the chain - Gap questionstep 03 of 04
The number of distinct ideas is to be determined by separately switching off and restoring the processes through which candidate interventions work. The distinction must survive comparison of lasting benefits across several body systems and effects on lifespan.
Rests on: The previous stage requires ideas to be different in their causes. This stage supplies a proposed way to distinguish those causes by interrupting and restoring their effects.
Stated in the chain - Hypothesisstep 04 of 04
One combined idea is proposed to require exactly two interventions: restoring mitochondrial maintenance, the upkeep of energy-producing structures inside cells, in heart and skeletal muscle cells; and removing chronically senescent fibroblasts, tissue-support cells that persist in a state of lasting growth arrest with altered functions. Each intervention alone is predicted to improve its immediate target while leaving another required source of decline in place. Reducing substances released by the persistent cells is predicted to replace neither repair.
Rests on: The preceding question supplies the requirement to distinguish causes through separate interruption and restoration. The endpoint supplies the specific biological premise that two different failures must both be corrected.
AssumptionThe proposed premise is that neither maintenance of the energy-producing structures nor removal of the persistent tissue-support cells can compensate for failure of the other, and that their combination is sufficient for the full lasting benefit. The supplied material does not establish this joint necessity or sufficiency.
What is carried, and what is not. Three screened sources speak to components of the proposal: S6 in Circulation (2026) reports restored cellular recycling and maintenance of energy-producing structures alongside improvement in the studied heart-dysfunction models, but does not test cell removal, skeletal muscle, or lifespan; S3 in eLife (2022) reports that metformin reduces release of reactive oxygen-containing molecules and inflammatory signals from senescent cells, but does not establish their removal or the proposed combined benefit; and the abstract supplied for S9 in Biochimica et Biophysica Acta, Molecular Basis of Disease (2023) links persistent senescent cells with tissue scarring and organ dysfunction, but does not test either intervention or their combination. These are supports for individual components, not the sequence as a whole: none of the supplied sources establishes that exactly these two interventions are jointly necessary and sufficient for lasting benefits across several body systems and longer life.S6S3S9
Where the reasoning is carried by something unstated · 1
- Hypothesis. The proposed premise is that neither maintenance of the energy-producing structures nor removal of the persistent tissue-support cells can compensate for failure of the other, and that their combination is sufficient for the full lasting benefit. The supplied material does not establish this joint necessity or sufficiency.
How a result here could mislead · 3
- Failure of either intervention alone could be read as evidence that both are necessary when the intervention did not adequately change its intended process, or the measurements were too uncertain to detect a useful effect. What closes it: The proposal requires verified effects on each intended process at several acceptable intervention intensities. It also requires interval estimates, ranges expressing uncertainty around an estimated effect, that exclude a useful benefit defined before testing; a result that merely fails a statistical significance test is insufficient.
- Benefit after cell removal could be credited to a separate repair process even if removal also restores maintenance of energy-producing structures in neighbouring cells, as one rival proposes. Likewise, loss of benefit after switching off one process could reflect unintended disruption of both. What closes it: Both processes must be measured under each intervention and during their separate interruption and restoration. The claimed specificity of those manipulations must be demonstrated so that a second process changing indirectly is distinguishable from two processes being independently required.
- A combination could appear uniquely successful because the definition of overall success was chosen after seeing which outcomes improved. Failure to detect an extra benefit from reducing cell secretions could also be mistaken for evidence that the addition makes no meaningful difference. What closes it: The common success criterion, the required duration of benefit, the body-system outcomes, and the lifespan outcome must be fixed before testing. The equivalence margin, the largest difference accepted as meaningfully negligible, must also be fixed in advance and assessed with uncertainty estimates. The supplied specification gives no numerical thresholds, durations, or margin.
What would make this wrong. The claim that both repairs are necessary would fail if either intervention alone met the predefined criterion for lasting benefits across several body systems and longer life, with its intended process verified as changed. It would also fail if the combined benefit persisted when either proposed required process was specifically switched off. The claim of sufficiency would fail if both processes were successfully restored together but the combination did not meet the success criterion. A reproducible added benefit from reducing cell secretions beyond the predefined equivalence margin would contradict the endpoint's prediction that this addition provides no meaningful further benefit.
What it would change. If the predicted pattern held, the search for broadly effective life-extension ideas would have to count this pair as one combined idea whose benefit requires both parts. Within the tested set, identifying different biological targets would no longer be enough to count separate sufficient interventions. That result would still not establish the combination's effects in humans, other tissues, or over other timescales: the supplied testing outline does not specify the species or duration, and it cannot establish how many such ideas exist outside the candidate set.
Sources read · 10
Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A. · Nutrients · 2026
“In aged mice, continuous dietary administration of fisetin (500 mg/kg diet) beginning at 85 weeks of age significantly extended both median and maximum lifespan.”
Does not settle: Источник не проверяет сочетание митохондриального обслуживания с удалением сенесцентных клеток, не устанавливает минимальный достаточный набор {M,C} и не показывает, что оба процесса необходимы для многосистемного или жизненного выигрыша.
ApoD mediates age-associated increase in vulnerability to influenza virus infection. · Proceedings of the National Academy of Sciences of the United States of America · 2025
“Removal of senescent cells in aged lung using the senolytic drug ABT-263 reduced ApoD levels, and alleviated pulmonary pathology in response to influenza virus infection.”
Does not settle: Источник не проверяет совместное применение двух вмешательств, их минимальную достаточность или необходимость для продления жизни. Он также не изучает обслуживание митохондрий в кардиомиоцитах и мышечных волокнах, удаление сенесцентных фибробластов, многосистемный функциональный выигрыш или роль R.
Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. · eLife · 2022
“Together, these data indicate that low, therapeutically relevant concentrations of metformin reduce the release of ROS and SASP cytokines from senescent cells, which can explain the senostatic activity of metformin in vivo.”
Does not settle: The source does not test a two-intervention set combining mitochondrial maintenance in cardiomyocytes or muscle fibres with clearance of senescent fibroblasts. It does not show senescent-cell removal, necessity of either intervention, their functional complementarity, or a long-term multisystem or lifespan benefit from their combination.
The role of mitochondria in cellular senescence. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
“Together, these observations suggest that mitochondria are intimately involved and potentially required for the induction and maintenance of the senescent state.”
Does not settle: Источник оставляет открытыми совместное применение M и C, восстановление митохондриального обслуживания кардиомиоцитов и мышечных волокон, удаление хронически сенесцентных фибробластов, минимальность набора {M,C}, а также длительный многосистемный выигрыш и продление жизни.
Beneficial effects of spermidine on cardiovascular health and longevity suggest a cell type-specific import of polyamines by cardiomyocytes. · Biochemical Society transactions · 2019
“Recent and exciting in vivo studies show that supplementation with the polyamine spermidine (Spd) is cardioprotective and prolongs lifespan in both mice and humans.”
Does not settle: It does not establish removal of senescent fibroblasts, a two-intervention set {M,C}, their necessity or sufficiency for multisystem longevity, or that either intervention alone leaves a separate required cause of decline.
Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis. · Circulation · 2026
“both genetic and pharmacological inhibition of KIF11 effectively restored autophagic flux and mitochondrial homeostasis, thereby reversing pathological cardiac remodeling in Asb2-deficient hearts and transverse aortic constriction-induced cardiac dysfunction.”
Does not settle: Источник не исследует удаление сенесцентных фибробластов, совместное применение двух воздействий, скелетные мышечные волокна, многосистемный эффект или продолжительность жизни.
Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia. · International journal of molecular sciences · 2022
“Figure 1 Schematic Representation of the Coordinated Regulation of the Mammalian Target of Rapamycin and Mitophagy in Muscle Protein Synthesis and Degradation.”
Does not settle: Источник не устанавливает, что сочетание M и C необходимо или достаточно для продления жизни; он не сообщает об удалении сенесцентных фибробластов, кардиомиоцитах, многосистемном эффекте или сравнении отдельных и совместных вмешательств.
Editorial: Mitochondria in Skeletal Muscle Health, Aging and Diseases. · Frontiers in physiology · 2016
“a growing interest now surrounds mechanisms involved in mitochondrial quality control (i.e., mechanisms responsible for the degradation of damaged / dysfunctional mitochondria).”
Does not settle: Источник не проверяет вмешательства M, C или R, их совместное применение, удаление сенесцентных фибробластов, минимальность набора {M,C}, многосистемный эффект или продление жизни.
Senescent cardiac fibroblasts: A key role in cardiac fibrosis. · Biochimica et biophysica acta. Molecular basis of disease · 2023
“However, the persistent presence of senescent cells within a tissue is linked with fibrosis development and organ dysfunction, leading to aging-related diseases such as cardiovascular pathologies.”
Does not settle: It does not test removal of senescent fibroblasts, mitochondrial upkeep, their combination, or effects on lifespan or multisystem function.
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis. · American journal of physiology. Lung cellular and molecular physiology · 2018
“Normally, once a senescent cell has contributed to wound repair, it is promptly removed from the environment via infiltrating immune cells. However, if immune clearance fails, the persistence of senescent cells is thought to drive disease pathology through their altered secretory profile.”
Does not settle: Источник не устанавливает, что удаление сенесцентных фибробластов является вмешательством C, и не оценивает совместное применение C с митохондриальным обслуживанием M. Он не сообщает о кардиомиоцитах, мышечных волокнах, продолжительности жизни, многосистемном эффекте или минимальном достаточном наборе {M,C}.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
How many distinct ways of extending life remain when targets are tested by disabling and restoring shared biological steps?
Original wording · exactly as the pipeline generated it
Сколько причинно самостоятельных идей «серебряных пуль» содержит проверяемый набор мишеней, если раздельное выключение и восстановление посредников должно определить, какие воздействия остаются различимыми по длительной пользе нескольким системам и продолжительности жизни?
What this question is asking
The question concerns how many genuinely separate routes to longer life are represented by a collection of biological targets. It asks whether switching off and then restoring mediators—the biological steps through which an intervention produces its effects—can distinguish interventions by their lasting benefits across several body systems and their effects on lifespan. Interventions would be compared over the same long observation period, and renaming an intervention or combining equivalent descriptions would not change the count. The question assumes that these dependency tests can support such a count, while allowing that shared mediators and limits on the benefit available may make different interventions look equivalent. The supplied material does not identify the complete target collection or specify that common observation period.
- Biological target
- A component or process that an intervention is intended to change. Different target names do not by themselves establish different routes to a benefit.
- Intervention
- A deliberate change, such as exercise, altered food intake, or disabling a gene, whose effects are assessed. Here, interventions are compared by their biological dependencies and lasting outcomes.
- Mediator and biological dependency
- A mediator is an intermediate biological step through which an intervention affects an outcome. An outcome depends on that step when disrupting it prevents the relevant effect in the tested setting; this does not establish that the step alone can produce the effect.
- Disabling and restoration
- Disabling reduces or removes a biological component's activity; restoration brings that component or its activity back. The question uses these changes to examine which effects depend on which steps.
- Causally independent routes and causal equivalence
- These describe whether interventions work through distinguishable chains of biological effects or can be grouped as the same route under a stated rule. They are proposed categories for counting, and the supplied material does not provide a complete rule for assigning them.
- Ceiling on benefit
- A limit beyond which a measured benefit no longer increases. Such a limit could make different interventions look similar, but its role in the intended target collection is not established.
- Muscle stem cells and activation
- Muscle stem cells are cells involved in maintaining and repairing muscle. Activation is their transition from a resting state toward activity involved in repair; S5 concerns their ability to make that transition in old mice.
- Cyclin D1
- A protein involved in controlling a cell's progression toward division. S5 identifies its restoration as necessary for recovery of the muscle stem-cell activation ability described there.
- Genes and genetically altered model
- Genes are inherited instructions that influence biological functions. A genetically altered model is an organism with an inherited change used to study a process; S6 concerns a particular worm model rather than all forms of reduced food intake.
- Autophagy
- A group of processes through which cells break down and recycle their own material. S6 concerns the requirement for this activity in the intestine in one worm lifespan model.
- Dietary restriction
- Reduced food intake or availability relative to a comparison condition. It covers different experimental arrangements; S6 concerns one genetic model of it.
- Insulin sensitivity
- How strongly the body responds to insulin, a hormone that helps regulate blood sugar. S8 measures changes in this response rather than lifespan.
- Oxygen-dependent metabolism
- The chemical processes through which cells use oxygen to help obtain energy. S8 reports indicators of these processes, which are measurements of selected features rather than a complete account of how the interventions work.
- Littermates
- Animals born in the same litter. The supplied S7 excerpt uses such animals as the comparison for mice lacking the candidate target.
Separate disabling and restoration of mediators can determine which interventions remain causally distinguishable by long-term benefits across several systems and lifespan, allowing a count that is unchanged by renaming or combining equivalent descriptions.
A mediator is a biological step between an intervention and its effects; disabling it tests whether an effect depends on that step, while restoring it examines whether the effect returns. The question assumes that these tests can sort a collection of interventions into genuinely different ways of producing lasting benefits and longer life. If that assumption holds, the count would reflect biological differences rather than the number of labels attached to targets.
S5 reports that recovery of activation ability in old mouse muscle stem cells depends on restoration of Cyclin D1. S6 reports that inhibiting cellular recycling in the intestine prevents the long lifespan of a particular worm model of restricted food intake. These support narrower claims about dependence on particular biological steps. Neither establishes a method for counting independent routes across a complete target collection using both disabling and restoration, a shared long-term comparison, benefits across several systems, and lifespan.S5S6
The same question asked without the part nothing read establishes:
- Which interventions in the target collection remain distinguishable in lasting benefits across several body systems and lifespan after shared biological steps are disabled and restored?
- What do the read sources establish about whether the candidate interventions depend on the same biological steps for their benefits?
- Several targets reduce to fewer routes If the dependency tests showed that differently named interventions produced their lasting benefits through the same route, those names would not establish separate opportunities to extend life. Treating every target as independent would then overcount the possibilities under the question's proposed counting rule.
- Several routes remain distinguishable If interventions retained different dependencies and different lasting effects after the tests, combining their descriptions would conceal biological differences. Under the question's proposed rule, those distinguishable routes would count separately.
- The tests leave the count unresolved If shared steps or a ceiling on measurable benefit made different routes produce indistinguishable results, the tests would not uniquely determine the count. An apparent match in outcomes would then leave open whether the interventions were equivalent or whether the comparison could not distinguish them.
An intervention may affect a target, which changes a mediator, which then changes how a body system functions. If several interventions depend on the same mediator, counting their names separately could overstate the number of independent opportunities to extend life. Conversely, similar measured benefits do not establish that the interventions work through the same route. Mistaking short-term improvement in one tissue for lasting benefits across several systems would also assign an intervention a broader effect than the supplied findings establish.
S-узлы описывают клеточные и иммунные механизмы уровней RL-1 и RL-2; метод проверки зависимостей доступен, причинные классы не подсчитаны.
Число самостоятельных идей, устойчивое к переименованию и объединению эквивалентных описаний, с различимыми прогнозами на общем хроническом горизонте.
Число названных мишеней неизвестным образом соотносится с числом самостоятельных возможностей продления жизни; общие посредники и насыщение могут скрывать различия.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
В наборе содержится одна составная самостоятельная идея с минимальным достаточным набором {M,C}, включающим ровно два воздействия. M восстанавливает митохондриальное обслуживание кардиомиоцитов и мышечных волокон, C удаляет хронически сенесцентные фибробласты, мешающие восстановлению ткани. Взаимное функциональное дополнение этих процессов необходимо для длительного многосистемного и жизненного выигрыша: каждый по отдельности улучшает ближайший показатель, но сохраняет вторую обязательную причину функционального ухудшения. R уменьшает секрецию, однако не заменяет ни обслуживание органелл, ни удаление клеток. Каталог минимальных достаточных наборов имеет вид {{M,C}}. Удаление любого элемента из этого набора лишает его достаточности.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Из семи активных сочетаний общий критерий успеха проходят только M+C и M+R+C; добавление R к M+C не улучшает результат сверх заранее заданной границы эквивалентности. Ни M, ни C по отдельности не достигают критерия даже при подтверждённом воздействии на мишень и при нескольких допустимых уровнях интенсивности. Специфическое выключение любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. Одиночная достаточность M, ожидаемая в гипотезе 01, или самостоятельная достаточность C, ожидаемая в гипотезах 02 и 03, опровергает этот набор.
Would tell it apart from at least one rival. The prediction specifies success comparisons, an equivalence condition, and loss and restoration of benefit following process removal and return. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Полный факторный план позволяет проверить обязательность сочетания. Для вывода о недостаточности одиночных воздействий нужны интервальные оценки, исключающие заранее установленный полезный эффект; простой статистически незначимый результат недостаточен.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Из семи активных сочетаний общий критерий успеха проходят только M+C и M+R+C; добавление R к M+C не улучшает результат сверх заранее заданной границы эквивалентности. Ни M, ни C по отдельности не достигают критерия даже при подтверждённом воздействии на мишень и при нескольких допустимых уровнях интенсивности. Специфическое выключение любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. Одиночная достаточность M, ожидаемая в гипотезе 01, или самостоятельная достаточность C, ожидаемая в гипотезах 02 и 03, опровергает этот набор.
- Rival 01 of 03What would separate them
Restoring mitochondrial renewal may account for all lasting benefits of the tested interventions predicts: При подтверждённом удалении сенесцентных клеток и снижении их секреции мягкое выключение митофагии только в сохраняющихся паренхиматозных клетках полностью устраняет длительную пользу C и R. Возврат митофагии восстанавливает пользу. Напротив, изолированное M сохраняет функциональный и жизненный выигрыш при экспериментальном удержании числа сенесцентных клеток и их воспалительной секреции около исходного уровня. Такой результат отличает единственный достаточный элемент {M} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.
- Rival 02 of 03What would separate them
Organelle renewal and senescent cell clearance may provide independent lasting benefits predicts: После выравнивания завершённого потока митофагии R перестаёт давать дополнительный длительный эффект. C сохраняет пользу при умеренном специфическом снижении M; M сохраняет пользу при снижении C. Возврат соответствующего посредника восстанавливает только его ветвь. Изотопное отслеживание переработки материала показывает два независимо изменяемых продуктивных потока. В отличие от гипотезы 01, C способен приносить пользу при ограниченном M; в отличие от гипотезы 03, R не сохраняет отдельного эффекта при фиксированном M; в отличие от гипотезы 04, одиночные M и C проходят общий критерий успеха.
- What would separate them
Organelle upkeep, secretion control and cell removal may independently extend life predicts: Каждое одиночное воздействие проходит общий критерий успеха и сохраняет часть пользы при специфическом ограничении двух других процессов. Для C подавление представления антигенов клетками-мишенями устраняет удаление клеток и длительный эффект; возврат представления антигенов восстанавливает оба результата. M и R сохраняют пользу в тех же условиях. Особенно различающий результат: R улучшает функции и выживаемость при экспериментально фиксированных потоке митофагии и числе сенесцентных клеток.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.